MENU
TYRA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Tyra Biosciences (TYRA) Ownership - Who owns Tyra Biosciences?
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology... Show more
Profile
Industry
N/A
Address
2656 State Street
Phone
+1 619 728-4760
Employees
49
Web
https://www.tyra.bio
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
535.68M
P/E Ratio
N/A
Total Cash
360.13M
Projected Growth
N/A
Total Debt
6.32M
Revenue
N/A
Risk (Beta)
1.30
Dividend Yield
N/A
Total Cash/Share
6.78
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
TYRA
Capitalization
536M
P/E Ratio
N/A
Risk (Beta)
1.30
Dividend Yield
N/A
Total Cash
360M
Total Cash/Share
6.78
Total Debt
6.32M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
362M
P/B Ratio
1.56
Cash Flow
N/A
Earnings
-1.61
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
29.55
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-99.59M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-27.06
Shares Held By Institutions
904M
Shares Outstanding - Current
53.1M
Total Liabilities
18.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-27.410
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2656 State Street
Phone
+1 619 728-4760
Employees
49
Web
https://www.tyra.bio